| Literature DB >> 33138699 |
Norah Ali AlGhamdi1,2, Hind Saleh Alsuwat1, J Francis Borgio1,3, Sayed AbdulAzeez1.
Abstract
SARS-CoV-2 is causative of pandemic COVID-19. There is a sequence similarity between SARS-CoV-2 and SARS-CoV; however, SARS-CoV-2 RBDs (receptor-binding domain) binds 20-fold strongly with human angiotensin-converting enzyme 2 (hACE2) than SARS-CoV. The study aims to investigate protein-protein interactions (PPI) of hACE2 with SARS-CoV-2 RBD between wild and variants to detect the most influential interaction. Variants of hACE2 were retrieved from NCBI and subjected to determine the most pathogenic nsSNPs. Probability of PPIs determines the binding affinity of hACE2 genetic variants with RBD was investigated. Composition variations at the hACE2 and RBD were processed for PatchDock and refined by FireDock for the PPIs. Twelve nsSNPs were identified as the top pathogenic from SNPs (n = 7489) in hACE2 using eight bioinformatics tools. Eight RBD variants were complexed with 12 nSNPS of hACE2, and the global energy scores (Kcal/mol) were calculated and classified as very weak (-3.93 to -18.43), weak (-18.42 to -32.94), moderate (-32.94 to -47.44), strong (-47.44 to -61.95) and very strong (-61.95 to -76.46) zones. Seven composition variants in the very strong zone [G726R-G476S; R768W-V367F; Y252N-V483A; Y252N-V367F; G726R-V367F; N720D-V367F and N720D-F486L], and three in very weak [P263S-S383C; RBD-H378R; G726R-A348T] are significantly (p < 0.00001) varied for global energy score. Zonation of the five zones was established based on the scores to differentiate the effect of hACE2 and RBD variants on the binding affinity. Moreover, our findings support that the combination of hACE2 and RBD is key players for the risk of infection that should be done by further laboratory studies.Communicated by Ramaswamy H. Sarma.Entities:
Keywords: ACE2; SARS-CoV-2; in silico software; nsSNPs; protein docking
Mesh:
Substances:
Year: 2020 PMID: 33138699 PMCID: PMC7651216 DOI: 10.1080/07391102.2020.1841032
Source DB: PubMed Journal: J Biomol Struct Dyn ISSN: 0739-1102
Figure 1.Predicting the effect of nsSNPs using various in silico tools.
The list of selected pathogenic nsSNPs out of 7489 SNPs.
| SNP | Coordinate | Substitution | Sift | Polyphen-2 | Panther | Provean | Snap2 | Snps&Go | Phd-SNP | Condel | CS | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P | S | P | S | P | P | S | P | S | P | S | P | S | P | Label | ||||
| rs148036434 | 15589801 | L595V | 1 | 0 | 1 | 1 | 1 | 1 | –2.56 | 1 | 16 | 1 | 0.69 | 1 | 0.727 | 1 | D | 9 |
| rs11798104 | 15593854 | W459C | 1 | 0 | 1 | 1 | 1 | 1 | –12.36 | 1 | 68 | 1 | 0.809 | 1 | 0.907 | 1 | D | 9 |
| rs142984500 | 15596376 | H378R | 1 | 0 | 1 | 1 | 1 | 1 | –7.93 | 1 | 70 | 1 | 0.879 | 1 | 0.906 | 1 | D | 9 |
| rs200745906 | 15605891 | P263S | 1 | 0 | 1 | 1 | 1 | 1 | –7.33 | 1 | 42 | 1 | 0.871 | 1 | 0.768 | 1 | D | 9 |
| rs371464495 | 15605924 | Y252N | 1 | 0.002 | 1 | 1 | 1 | 1 | –6.84 | 1 | 82 | 1 | 0.815 | 1 | 0.931 | 1 | D | 9 |
| rs375352455 | 15589896 | S563L | 1 | 0.001 | 1 | 1 | 1 | 1 | –5.78 | 1 | 48 | 1 | 0.716 | 1 | 0.862 | 1 | D | 8 |
| rs139980377 | 15582280 | G726R | 1 | 0.004 | 1 | 1 | 1 | 1 | –2.82 | 1 | 79 | 0 | 0.206 | 1 | 0.778 | 1 | D | 8 |
| rs140016715 | 15582154 | R768W | 1 | 0 | 1 | 1 | 1 | 1 | –2.82 | 1 | 62 | 1 | 0.517 | 1 | 0.853 | 1 | D | 8 |
| rs267606408 | 15603648 | P284S | 0 | 0.053 | 1 | 0.991 | 1 | 1 | –7.65 | 0 | 0 | 1 | 0.838 | 1 | 0.864 | 1 | D | 7 |
| rs41303171 | 15582298 | N720D | 0 | 0.092 | 0 | 0.006 | 1 | 0 | –1.19 | 0 | –32 | 0 | 0.139 | 1 | 0.5 | 1 | D | 3# |
| rs143936283 | 15599428 | E329G | 0 | 0.121 | 0 | 0.027 | 0 | 0 | –2.21 | 1 | 5 | 0 | 0.108 | 0 | 0.343 | 1 | D | 2*# |
| rs146676783| | 15618926 | E37K | 0 | 0.16 | 1 | 0.712 | 1 | 0 | –1.86 | 0 | –35 | 0 | 0.175 | 0 | 0.449 | 0 | N | 2* |
CS: Cumulative Score; P: Prediction; S: Score. * These two amino acid substitutions were selected as they are reported as contact residues of RBD–hACE2 (Lan et al., 2020). # SNP was observed in the Saudi population and was added for the regional interest. The values in P: 0 indicates neutral (N); 1 indicated damaged (D).
Figure 2.Three-dimensional structures and their validations of A&B: hACE2, and C&D: SARS-CoV-2 spike protein.
Figure 3.Annotation of SARS-CoV-2 variants in the multiple sequence alignment of the spike protein sequence and reported variants. Arrow indicates the amino acid substitutions.
Figure 4.Phylogenetic analysis of SARS-CoV-2 spike protein was accomplished through maximum-likehood 8000 bootstrap. The list of sequences used to construct phylogeny are listed in the Supplementary Data 1.
Figure 5.3D structures of wild and variants of hACE2 receptor and SARS-CoV-2 spike protein.
RMSD calculations for hACE2 and SARS-CoV-2 spike protein variants.
| hACE2 receptor variants | SARS-CoV-2 spike protein variants | ||||
|---|---|---|---|---|---|
| nsSNPs | Residue Change | RMSD | Number | Residue Change | RMSD |
| rs148036434 | L595V | 0.06 | QIS30335 | A348T | 1.488 |
| rs11798104 | W459C | 0.06 | 6X29_A | S383C | 1.488 |
| rs142984500 | H378R | 0.06 | QJA16640 | A419S | 1.488 |
| rs143936283 | E329G | 0.06 | QIQ49882 | G476S | 3.2 |
| rs267606408 | P284S | 0.06 | QIS30425 | G476S | 3.2 |
| rs200745906 | P263S | 0.06 | QIS30165 | V483A | 3.2 |
| rs371464495 | Y252N | 0.06 | QJS39567 | F486L | 3.2 |
| rs146676783 | E37K | 0.06 | QIS60489 | A520S | 1.488 |
| rs375352455 | S563L | 0.06 | QK95522.1 | V367F | 1.488 |
| rs139980377 | G726R | 0.05 | |||
| rs140016715 | R768W | 0.06 | |||
| rs41303171 | N720D | 1.514 | |||
Figure 6.Significant composition variations of hACE2 receptor and SARS-CoV-2 spike protein. A: Very weak Composition variation. B & C: Very strong composition variations.
Figure 7.A: Heat map of Global energy score for composition variations of hACE2 and SARS-CoV-2 spike protein-generated Heatmapper (http://www.heatmapper.ca/pairwise/) with matrix of Displaying data as-is. and their significant impact; B: graphical representations of all composition variations that reflect the degree of binding to SARS-CoV-2.